Generex Biotechnology Subsidiary Olaregen Therapeutix Receives VAC Approval and Ships Excellagen® to the Arizona Indian Health Service

NEXT STORY
Genesis HealthCare Enters into Agreements with New Generation Health to Transition the Operations of 19 West Coast Facilities
PREV STORY
Greenbrook TMS NeuroHealth Centers Now Offer BrainsWay’s Deep Transcranial Magnetic Stimulation (Deep TMS) for Obsessive-Compulsive Disorder (OCD) at Two Locations in St. Louis, Missouri
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Priority Review Granted to BeiGene’s New Drug Applications for Zanubrutinib and Tislelizumab in China

CAMBRIDGE, Mass., and BEIJING, China, Nov. 15, 2018 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ: ...

author_avatar
NASDAQ Market News

Persidangan Dunia tentang Persidangan Akhbar Kanser Paru-Paru Hari Selasa: Meningkatkan Kadar Penyembuhan untuk Kanser Paru-Paru Tahap III

TORONTO, Sept. 27, 2018 (GLOBE NEWSWIRE) -- Persidangan akhbar hari ini di Persatuan Antarabangsa ...

author_avatar
NASDAQ Market News

ProLynx announces PLX039, a hydrogel-microsphere drug delivery system that supports once-monthly administration of a GLP-1 receptor agonist

SAN FRANCISCO, June 12, 2017 (GLOBE NEWSWIRE) -- In a late-breaking abstract at the ...

author_avatar
NASDAQ Market News